Listed

Processa Pharmaceuticals, Inc.

PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Processa Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2017-10-1716:26 ET8-K/A1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001393905-17-000317
2017-10-1222:05 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001393905-17-000309
2017-10-0519:53 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001393905-17-000303
2017-10-0416:13 ET10-QQuarterly reportPeriod 2017-06-300001393905-17-000302
2017-10-0410:14 ET10-QQuarterly reportPeriod 2017-03-310001393905-17-000299
2017-09-2512:21 ET10-KAnnual reportPeriod 2016-12-310001393905-17-000290
2017-09-0815:29 ET10-QQuarterly reportPeriod 2016-09-300001393905-17-000272
2017-08-3016:49 ET10-QQuarterly reportPeriod 2016-06-300001393905-17-000269
2017-08-2417:17 ET8-K5.02 Departure or appointment of officers or directors0001393905-17-000255
2017-08-0716:55 ET10-QQuarterly reportPeriod 2016-03-310001393905-17-000223
2017-07-1810:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-17-000208
2017-06-1914:46 ET10-KAnnual reportPeriod 2015-12-310001393905-17-000190
2015-12-0119:07 ET10-QQuarterly reportPeriod 2015-09-300001393905-15-000641
2015-09-2215:12 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001393905-15-000493
2015-09-1715:32 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001393905-15-000482
2015-09-1417:12 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000473
2015-09-1016:50 ET8-K4.01 Change of auditor0001393905-15-000453
2015-09-0416:52 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000446
2015-08-1915:59 ET10-QQuarterly reportPeriod 2015-06-300001393905-15-000427
2015-08-0615:02 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000380
2015-07-0717:01 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-15-000346
2015-06-0215:07 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000302
2015-05-1514:20 ET10-QQuarterly reportPeriod 2015-03-310001393905-15-000259
2015-05-0616:46 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000227
2015-04-1417:00 ET10-KAnnual reportPeriod 2014-12-310001393905-15-000193
2015-03-2416:02 ET8-K5.02 Departure or appointment of officers or directors0001393905-15-000126
2015-02-2016:47 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001393905-15-000075
2014-11-1316:56 ET10-QQuarterly reportPeriod 2014-09-300001393905-14-000606
2014-11-1015:42 ET8-K5.02 Departure or appointment of officers or directors0001393905-14-000589
2014-11-0317:19 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001393905-14-000583
2014-10-2916:58 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001393905-14-000577
2014-10-0117:19 ET8-K3.03 Change to security holders’ rights0001393905-14-000549
2014-09-2618:39 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-14-000537
2014-08-1918:44 ET10-QQuarterly reportPeriod 2014-06-300001393905-14-000488
2014-08-0709:56 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-14-000437
2014-06-2516:52 ET8-K5.02 Departure or appointment of officers or directors0001393905-14-000381
2014-06-0514:28 ET8-K3.02 Unregistered sale of equity0001393905-14-000338
2014-05-2709:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001019687-14-002138
2014-05-1415:44 ET10-QQuarterly reportPeriod 2014-03-310001393905-14-000288
2014-03-2715:39 ET10-KAnnual reportPeriod 2013-12-310001393905-14-000131
2014-03-0514:32 ET8-K3.02 Unregistered sale of equity; 8.01 Other events0001393905-14-000084
2014-01-2210:17 ET8-K2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors0001393905-14-000028
2014-01-0917:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001393905-14-000013
2013-11-2717:27 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001393905-13-000679
2013-11-0816:42 ET10-QQuarterly reportPeriod 2013-09-300001393905-13-000601
2013-10-2815:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-13-000589
2013-10-2117:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-13-000567
2013-09-2716:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-13-000541
2013-09-0616:14 ET10-Q/AQuarterly report, amendedPeriod 2013-06-300001393905-13-000498
2013-09-0613:35 ET8-K3.02 Unregistered sale of equity0001393905-13-000496

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.